Phase 4Not yet recruiting
Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder
A Double-Blind, Placebo-Controlled, Multicenter Study of Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder
- Sponsor
- Bausch Health Americas, Inc. (Industry)
- Enrollment
- 246 planned
- Conditions
- Major Depressive Disorder
- Interventions
- bupropion hydrobromide; Placebo
- Ages
- children
- Registry
- NCT02129751
Full record on ClinicalTrials.gov
From the registry
Double-Blind, Placebo-Controlled, Multicenter Study of Efficacy and Safety
Primary outcomes
- Mean change from Baseline to EOT in total CDRS-R (raw) score
History
Study completion expected
Primary completion expected
Expected to start
Last registry update
Registered